HLA-C and neoplasm: This MHC-unrestricted recognition equips γδ T cells with a unique advantage in targeting tumor cells that have undergone immune evasion via antigen loss or MHC downregulation, a common mechanism of resistance seen in solid tumors and hematologic malignancies.